1Osanai T,Tanaka M,Kamada T,et al. Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor. J Clin Invest, 2001,108 : 1023-1030.
2Osanai T, Kamada T, Fujiwara N, et al. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem, 1998,273 : 31778-31783.
3Osanai T, Tanaka M, Kamada T, et al. Molecular coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress. Circulation, 2001, 104,3132-3136.
4sharifi AM,Schiffrin EL. Apoptosis in vasculature of spontaneously hypertensive rats:effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am J Hypertens,1998,11:11086
5Fortuno MA, Ravassa S, Etayo J C, et al. Overexpression of bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: effects of AT: blockade with losartan. Hypertension, 1998,32 : 580-586.
6Sangawa H, Himeda T, Shibata H, et al. Gene expression of subunit c(P1 ), subunit c(P2), and oligomycin sensitivity conferring protein may play a key role in biogenesis of H+2ATP synthase in various rat tissues. J Biol Chem, 1997,272 : 6034- 6037.
7Xiaolu Li, Shanshan Xing, Like Zhang, et al. Glucose promotes the release and expression of novel vasoactive peptide, coupling factor 6,in human umbilical vein endothelial cells. Peptides, 2007,28 : 683-690.
8Ando J,Tsuboi H, Korenaga R, et al. Differential display and cloning of shear stress-responsive messenger RNAs in human endothelial cells. Biochem Biophys Res Commun, 1996,225: 347-351.
9Osanai T,Nakamura M,Sasaki S ,et al. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int, 2003,64 : 2291-2297.
10Tanaka M, Osanai T, Murakami R, et al. Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells., enhanced release of asymmetric dimethylarginine. Am J Hypertens,2006,24:489-497.
二级参考文献7
1Osanai T, Tanaka M, Kamada T et al. Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor. J Clin Invest, 2001, 108 (7) :1023 - 1030.
2Osanai T, Kamada T, Fujiwara Net al. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensove. J Biol Chem, 1998, 27, 273 ( 48 ) :31778 - 83.
3Osanai T, Tanaka M, Kamada T et al. Molecular coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress. Circulation, 2001, 104:3132 -3136.
4Chinenov Y, Coombs C, Martin ME et al. Isolation of a bi - directional promoter directing expression of the mouse GABP alpha and ATPsynthase coupling factor 6 genes. Gene, 2000, 261 (2) : 311 -320.
5sasaki S, Osanai T, Tomita Het al. Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6. Cardiovase Bes,2004, 62 (3): 578-586.
6Osanai T, Nakamura M, Sasaki Set al. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end - stage renal disease. Kidney Int, 2003, 64 (6): 2291-2297.
